This EUnetHTA 21 deliverable (D4.6) focusses on the methodological guidance regarding the validity of clinical studies. The objective of this deliverable is to consensually develop a practical guideline on how to consider, classify and label various types of evidence in the assessment reports, including real world data and data from basket trials, to support authors of JCA/CA in understanding, selecting, and critically appraising clinical evidence. This will also address the general principles which determine the certainty of results (e.g. internal validity, external validity, and statistical precision). The other objective is to check the existing EUnetHTA guidelines/SOPs for consistency with the practical guideline and consider updates.
The public consultation for this specific deliverable is foreseen to take place in the period between 04-07-2022 and 02-08-2022.
For any questions regarding this deliverable, please contact JCA_Secretariat@zinl.nl
Below you can find the published documentation:
D4.6 Validity of clinical studies – Project Plan
This website was produced under the Third EU Health Programme through a service contract with the European Health and Digital Executive Agency (HaDEA) acting under the mandate from the European Commission. The information and views set out in this website are those of the author(s) and do not necessarily reflect the official opinion of the Commission/Executive Agency. The Commission/Executive Agency do not guarantee the accuracy of the data included in this website. Neither the Commission/Executive Agency nor any person acting on the Commission’s/Executive Agency’s behalf may be held responsible for the use which may be made of the information contained therein.
©2021 EUnetHTA All rights reserved.